IRVINE, Calif., April 23, 2026 — Bright Uro, Inc., the company transforming care for lower urinary tract dysfunction (LUTD) through innovations in urodynamics, today announced the launch of the Glean Registry — enabling the collection of de-identified information to capture key findings and insights from commercial use of the Glean® Urodynamics System. The registry marks a significant milestone as Bright Uro continues its efforts to build the future of urodynamics.
The Glean Registry will help build a comprehensive data repository, enabling the company to generate meaningful insights for clinicians treating patients across the entire range of LUTD, including overactive bladder (OAB), stress urinary incontinence (SUI), benign prostatic hyperplasia (BPH), and neurogenic LUTD (NLUTD). Enrollment into the Registry is actively underway for current Glean users.